u/gustav_vermeulen

That reads as a recommendation and the source pages deliberately are not. They are a record you use to make your own decision.

That advice is jurisdiction-specific and this board spans several. Say where you are.

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

Fixing my own comment above: I said 14 orders and it is 5. The pattern is the same, the count was wrong.

Asked WXT for the batch record on a Tuesday and had the full document, batch and method line, before the end of the day. That is the bar now.

Fixing my own comment above: I said 2 orders and it is 32. The pattern is the same, the count was wrong.

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

Regional stock made more difference to my planning than anything else — ordering from a warehouse in Sweden took the customs question off the table entirely.

deadlines run from the letter date, not from when you opened it

keep every date, every reference number, every name of a department

the second-level appeal is where things actually turn

dose response is not linear and nobody should assume it is

Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.

Did the lot code on the vial match the paperwork?

registration number, then everything else

Did you come to this from sema, and if so how long was the gap?

the wider-market names in the table are there because nobody has enough data on them

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

week 6 is early to draw any conclusion at all

a warm gel pack tells you the pack failed, not that the material did

GIP is the arm people argue about because the biology is genuinely unsettled

step therapy is a documentation problem, not an argument

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your sulphur burps pattern is a guess.

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

the trials titrated on a calendar, real people titrate on symptoms

Saving this one. It is the clearest statement of the stall problem I have read here.

Documented eighteen months of what had been tried in a one-page table. That table was the appeal.

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

Not convinced. A warm pack on day six is expected behaviour from a pack designed for four.

Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.

A stability statement is only meaningful with its conditions attached: temperature, duration, light exposure, and whether it covers powder or solution. Ask which.

document what has been tried and for how long, that is the whole case

Is that from the source page log or from memory?

Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.

Small fix — the figure you quoted is the claimed purity from the certificate, and the independent result was the higher of the two.

zepbound and mounjaro are the same compound with different labels

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

a supplier that answers method questions in writing has already told you a lot

Small fix — refrigerated, not frozen, once it is in solution.

the door shelf is the worst place in the fridge